Sixuan Li is the Founder and CEO of CICS Analytics, a company focused on single-particle analysis technology for RNA nanoparticle therapeutics, which they established in 2024. Currently a postdoctoral research associate at Johns Hopkins University, Sixuan completed a PhD in BioMEMS and single-molecule techniques at the same institution in 2023. Previously, Sixuan held roles as a control system engineer at BAIC Group and excelled as a graduate research assistant, where they developed advanced microfluidic systems and contributed to significant publications. Additionally, Sixuan is an expert panel member for US Pharmacopeia's best practices for mRNA vaccines from 2025 to 2030.
This person is not in the org chart
This person is not in any teams
This person is not in any offices